Skip to main content
Erschienen in: Brain Structure and Function 4/2010

01.05.2010 | Review

Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

verfasst von: Per Borghammer, Mallar Chakravarty, Kristjana Yr Jonsdottir, Noriko Sato, Hiroshi Matsuda, Kengo Ito, Yutaka Arahata, Takashi Kato, Albert Gjedde

Erschienen in: Brain Structure and Function | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Recent cerebral blood flow (CBF) and glucose consumption (CMRglc) studies of Parkinson’s disease (PD) revealed conflicting results. Using simulated data, we previously demonstrated that the often-reported subcortical hypermetabolism in PD could be explained as an artifact of biased global mean (GM) normalization, and that low-magnitude, extensive cortical hypometabolism is best detected by alternative data-driven normalization methods. Thus, we hypothesized that PD is characterized by extensive cortical hypometabolism but no concurrent widespread subcortical hypermetabolism and tested it on three independent samples of PD patients. We compared SPECT CBF images of 32 early-stage and 33 late-stage PD patients with that of 60 matched controls. We also compared PET FDG images from 23 late-stage PD patients with that of 13 controls. Three different normalization methods were compared: (1) GM normalization, (2) cerebellum normalization, (3) reference cluster normalization (Yakushev et al.). We employed standard voxel-based statistics (fMRIstat) and principal component analysis (SSM). Additionally, we performed a meta-analysis of all quantitative CBF and CMRglc studies in the literature to investigate whether the global mean (GM) values in PD are decreased. Voxel-based analysis with GM normalization and the SSM method performed similarly, i.e., both detected decreases in small cortical clusters and concomitant increases in extensive subcortical regions. Cerebellum normalization revealed more widespread cortical decreases but no subcortical increase. In all comparisons, the Yakushev method detected nearly identical patterns of very extensive cortical hypometabolism. Lastly, the meta-analyses demonstrated that global CBF and CMRglc values are decreased in PD. Based on the results, we conclude that PD most likely has widespread cortical hypometabolism, even at early disease stages. In contrast, extensive subcortical hypermetabolism is probably not a feature of PD.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, Iwai K, Ito K, Yanagisawa N, Sobue G (2003) Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74:419–422PubMedPubMedCentralCrossRef Abe Y, Kachi T, Kato T, Arahata Y, Yamada T, Washimi Y, Iwai K, Ito K, Yanagisawa N, Sobue G (2003) Occipital hypoperfusion in Parkinson’s disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 74:419–422PubMedPubMedCentralCrossRef
Zurück zum Zitat Agniel A, Celsis P, Viallard G, Montastruc JL, Rascol O, Demonet JF, Marc-Vergnes JP, Rascol A (1991) Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. J Neurol Neurosurg Psychiatry 54:783–786PubMedPubMedCentralCrossRef Agniel A, Celsis P, Viallard G, Montastruc JL, Rascol O, Demonet JF, Marc-Vergnes JP, Rascol A (1991) Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. J Neurol Neurosurg Psychiatry 54:783–786PubMedPubMedCentralCrossRef
Zurück zum Zitat Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Kostler H, Hecker H, Burchert W (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79PubMedCrossRef
Zurück zum Zitat Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G (2001) Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson’s disease. Neurol Sci 22:45–46PubMedCrossRef Antonini A, De Notaris R, Benti R, De Gaspari D, Pezzoli G (2001) Perfusion ECD/SPECT in the characterization of cognitive deficits in Parkinson’s disease. Neurol Sci 22:45–46PubMedCrossRef
Zurück zum Zitat Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, Ikeda M, Ito K, Sobue G (1999) Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure. J Neurol Sci 163:119–126PubMedCrossRef Arahata Y, Hirayama M, Ieda T, Koike Y, Kato T, Tadokoro M, Ikeda M, Ito K, Sobue G (1999) Parieto-occipital glucose hypometabolism in Parkinson’s disease with autonomic failure. J Neurol Sci 163:119–126PubMedCrossRef
Zurück zum Zitat Ben-Shachar D, Bonne O, Chisin R, Klein E, Lester H, Aharon-Peretz J, Yona I, Freedman N (2007) Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study. Prog Neuropsychopharmacol Biol Psychiatry 31:807–813PubMedCrossRef Ben-Shachar D, Bonne O, Chisin R, Klein E, Lester H, Aharon-Peretz J, Yona I, Freedman N (2007) Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study. Prog Neuropsychopharmacol Biol Psychiatry 31:807–813PubMedCrossRef
Zurück zum Zitat Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH (2001) Resting regional cerebral glucose metabolism in advanced Parkinson’s disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16:1014–1022PubMedCrossRef Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH (2001) Resting regional cerebral glucose metabolism in advanced Parkinson’s disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16:1014–1022PubMedCrossRef
Zurück zum Zitat Bes A, Guell A, Fabre N, Dupui P, Victor G, Geraud G (1983) Cerebral blood flow studied by Xenon-133 inhalation technique in parkinsonism: loss of hyperfrontal pattern. J Cereb Blood Flow Metab 3:33–37PubMedCrossRef Bes A, Guell A, Fabre N, Dupui P, Victor G, Geraud G (1983) Cerebral blood flow studied by Xenon-133 inhalation technique in parkinsonism: loss of hyperfrontal pattern. J Cereb Blood Flow Metab 3:33–37PubMedCrossRef
Zurück zum Zitat Biesold D, Inanami O, Sato A, Sato Y (1989) Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neurosci Lett 98:39–44PubMedCrossRef Biesold D, Inanami O, Sato A, Sato Y (1989) Stimulation of the nucleus basalis of Meynert increases cerebral cortical blood flow in rats. Neurosci Lett 98:39–44PubMedCrossRef
Zurück zum Zitat Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE (1999) Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia. Neurology 52:541–546PubMedCrossRef Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE (1999) Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia. Neurology 52:541–546PubMedCrossRef
Zurück zum Zitat Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A (2008) Normalization in PET group comparison studies—the importance of a valid reference region. Neuroimage 40:529–540PubMedCrossRef Borghammer P, Jonsdottir KY, Cumming P, Ostergaard K, Vang K, Ashkanian M, Vafaee M, Iversen P, Gjedde A (2008) Normalization in PET group comparison studies—the importance of a valid reference region. Neuroimage 40:529–540PubMedCrossRef
Zurück zum Zitat Borghammer P, Aanerud J, Gjedde A (2009a) Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46(4):981–988PubMedCrossRef Borghammer P, Aanerud J, Gjedde A (2009a) Data-driven intensity normalization of PET group comparison studies is superior to global mean normalization. Neuroimage 46(4):981–988PubMedCrossRef
Zurück zum Zitat Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A (2009b) Subcortical elevation of metabolism in Parkinson’s disease—a critical reappraisal in the context of global mean normalization. Neuroimage 47(4):1514–1521PubMedCrossRef Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A (2009b) Subcortical elevation of metabolism in Parkinson’s disease—a critical reappraisal in the context of global mean normalization. Neuroimage 47(4):1514–1521PubMedCrossRef
Zurück zum Zitat Borghammer P, Cumming P, Aanerud J, Gjedde A (2009c) Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson’s disease. Neuroimage 45:249–257PubMedCrossRef Borghammer P, Cumming P, Aanerud J, Gjedde A (2009c) Artefactual subcortical hyperperfusion in PET studies normalized to global mean: lessons from Parkinson’s disease. Neuroimage 45:249–257PubMedCrossRef
Zurück zum Zitat Borghammer P, Ostergaard K, Cumming P, Gjedde A, Rodell A, Hall N, Chakravarty MM (2009d) A deformation-based morphometry study of patients with early-stage Parkinson’s disease. Eur J Neurol [Epub ahead of print] Borghammer P, Ostergaard K, Cumming P, Gjedde A, Rodell A, Hall N, Chakravarty MM (2009d) A deformation-based morphometry study of patients with early-stage Parkinson’s disease. Eur J Neurol [Epub ahead of print]
Zurück zum Zitat Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211PubMedCrossRef
Zurück zum Zitat Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, Hof PR (2007) Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 164:1072–1081PubMedCrossRef Buchsbaum MS, Buchsbaum BR, Hazlett EA, Haznedar MM, Newmark R, Tang CY, Hof PR (2007) Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry 164:1072–1081PubMedCrossRef
Zurück zum Zitat Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800PubMedCrossRef Burton EJ, McKeith IG, Burn DJ, Williams ED, O’Brien JT (2004) Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls. Brain 127:791–800PubMedCrossRef
Zurück zum Zitat Cudennec A, Bonvento G, Duverger D, Lacombe P, Seylaz J, MacKenzie ET (1993) Effects of dorsal raphe nucleus stimulation on cerebral blood flow and flow-metabolism coupling in the conscious rat. Neuroscience 55:395–401PubMedCrossRef Cudennec A, Bonvento G, Duverger D, Lacombe P, Seylaz J, MacKenzie ET (1993) Effects of dorsal raphe nucleus stimulation on cerebral blood flow and flow-metabolism coupling in the conscious rat. Neuroscience 55:395–401PubMedCrossRef
Zurück zum Zitat Dagher A, Nagano-Saito A (2007) Functional and anatomical magnetic resonance imaging in Parkinson’s disease. Mol Imaging Biol 9:234–242PubMedCrossRef Dagher A, Nagano-Saito A (2007) Functional and anatomical magnetic resonance imaging in Parkinson’s disease. Mol Imaging Biol 9:234–242PubMedCrossRef
Zurück zum Zitat Duvernoy HM (1999) The human brain: surface, three-dimensional sectional anatomy with MRI, and blood supply. Springer, ViennaCrossRef Duvernoy HM (1999) The human brain: surface, three-dimensional sectional anatomy with MRI, and blood supply. Springer, ViennaCrossRef
Zurück zum Zitat Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson’s disease without dementia. Neurobiol Aging 15:329–335PubMedCrossRef Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994) Cortical glucose metabolism in Parkinson’s disease without dementia. Neurobiol Aging 15:329–335PubMedCrossRef
Zurück zum Zitat Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26:912–921PubMedCrossRef Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, Eidelberg D (2005) FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 26:912–921PubMedCrossRef
Zurück zum Zitat Eckert T, Van Laere K, Tang C, Lewis DE, Edwards C, Santens P, Eidelberg D (2007) Quantification of Parkinson’s disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 34:496–501PubMedCrossRef Eckert T, Van Laere K, Tang C, Lewis DE, Edwards C, Santens P, Eidelberg D (2007) Quantification of Parkinson’s disease-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging 34:496–501PubMedCrossRef
Zurück zum Zitat Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA (1990) The metabolic anatomy of Parkinson’s disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Mov Disord 5:203–213PubMedCrossRef Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, Cedarbaum J, Greene P, Fahn S, Rottenberg DA (1990) The metabolic anatomy of Parkinson’s disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Mov Disord 5:203–213PubMedCrossRef
Zurück zum Zitat Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783–801PubMedCrossRef Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S et al (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783–801PubMedCrossRef
Zurück zum Zitat Eidelberg D, Moeller JR, Antonini A, Kazumata K, Nakamura T, Dhawan V, Spetsieris P, deLeon D, Bressman SB, Fahn S (1998) Functional brain networks in DYT1 dystonia. Ann Neurol 44:303–312PubMedCrossRef Eidelberg D, Moeller JR, Antonini A, Kazumata K, Nakamura T, Dhawan V, Spetsieris P, deLeon D, Bressman SB, Fahn S (1998) Functional brain networks in DYT1 dystonia. Ann Neurol 44:303–312PubMedCrossRef
Zurück zum Zitat Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, Mentis MJ, Moeller JR, Eidelberg D (2002) Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265–1270PubMedCrossRef Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, Mentis MJ, Moeller JR, Eidelberg D (2002) Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265–1270PubMedCrossRef
Zurück zum Zitat Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT (2003) Regional cerebral blood flow in Parkinson’s disease with and without dementia. Neuroimage 20:1309–1319PubMedCrossRef Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O’Brien JT (2003) Regional cerebral blood flow in Parkinson’s disease with and without dementia. Neuroimage 20:1309–1319PubMedCrossRef
Zurück zum Zitat Fox PT, Mintun MA, Reiman EM, Raichle ME (1988) Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8:642–653PubMedCrossRef Fox PT, Mintun MA, Reiman EM, Raichle ME (1988) Enhanced detection of focal brain responses using intersubject averaging and change-distribution analysis of subtracted PET images. J Cereb Blood Flow Metab 8:642–653PubMedCrossRef
Zurück zum Zitat Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson’s disease. Parkinsonism Relat Disord 15:144–148PubMedCrossRef Frisina PG, Haroutunian V, Libow LS (2009) The neuropathological basis for depression in Parkinson’s disease. Parkinsonism Relat Disord 15:144–148PubMedCrossRef
Zurück zum Zitat Gai WP, Halliday GM, Blumbergs PC, Geffen LB, Blessing WW (1991) Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson’s disease. Brain 114(Pt 5):2253–2267PubMedCrossRef Gai WP, Halliday GM, Blumbergs PC, Geffen LB, Blessing WW (1991) Substance P-containing neurons in the mesopontine tegmentum are severely affected in Parkinson’s disease. Brain 114(Pt 5):2253–2267PubMedCrossRef
Zurück zum Zitat German DC, Manaye KF, White CL III, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676PubMedCrossRef German DC, Manaye KF, White CL III, Woodward DJ, McIntire DD, Smith WK, Kalaria RN, Mann DM (1992) Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 32:667–676PubMedCrossRef
Zurück zum Zitat Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, Heiss WD (2002) Monosymptomatic resting tremor and Parkinson’s disease: a multitracer positron emission tomographic study. Mov Disord 17:782–788PubMedCrossRef Ghaemi M, Raethjen J, Hilker R, Rudolf J, Sobesky J, Deuschl G, Heiss WD (2002) Monosymptomatic resting tremor and Parkinson’s disease: a multitracer positron emission tomographic study. Mov Disord 17:782–788PubMedCrossRef
Zurück zum Zitat Globus M, Mildworf B, Melamed E (1985) Cerebral blood flow and cognitive impairment in Parkinson’s disease. Neurology 35:1135–1139PubMedCrossRef Globus M, Mildworf B, Melamed E (1985) Cerebral blood flow and cognitive impairment in Parkinson’s disease. Neurology 35:1135–1139PubMedCrossRef
Zurück zum Zitat Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, Drzezga A, Stern Y (2008) Multivariate and univariate neuroimaging biomarkers of Alzheimer’s disease. Neuroimage 40:1503–1515PubMedCrossRef Habeck C, Foster NL, Perneczky R, Kurz A, Alexopoulos P, Koeppe RA, Drzezga A, Stern Y (2008) Multivariate and univariate neuroimaging biomarkers of Alzheimer’s disease. Neuroimage 40:1503–1515PubMedCrossRef
Zurück zum Zitat Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice 4:600–609PubMedCrossRef Henchcliffe C, Beal MF (2008) Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nature clinical practice 4:600–609PubMedCrossRef
Zurück zum Zitat Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84:5976–5980PubMedPubMedCentralCrossRef Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84:5976–5980PubMedPubMedCentralCrossRef
Zurück zum Zitat Hosey LA, Thompson JL, Metman LV, van den Munckhof P, Braun AR (2005) Temporal dynamics of cortical and subcortical responses to apomorphine in Parkinson disease: an H2(15)O PET study. Clin Neuropharmacol 28:18–27PubMedCrossRef Hosey LA, Thompson JL, Metman LV, van den Munckhof P, Braun AR (2005) Temporal dynamics of cortical and subcortical responses to apomorphine in Parkinson disease: an H2(15)O PET study. Clin Neuropharmacol 28:18–27PubMedCrossRef
Zurück zum Zitat Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ (2000) Cortical dysfunction in non-demented Parkinson’s disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123(Pt 2):340–352PubMedCrossRef Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ, Koepp MJ, Hammers A, Morris RG, Turjanski N, Brooks DJ (2000) Cortical dysfunction in non-demented Parkinson’s disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123(Pt 2):340–352PubMedCrossRef
Zurück zum Zitat Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson’s disease. Brain 130:1834–1846PubMedCrossRef Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson’s disease. Brain 130:1834–1846PubMedCrossRef
Zurück zum Zitat Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N (1999) SPECT image analysis using statistical parametric mapping in patients with Parkinson’s disease. J Nucl Med 40:1583–1589PubMed Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N (1999) SPECT image analysis using statistical parametric mapping in patients with Parkinson’s disease. J Nucl Med 40:1583–1589PubMed
Zurück zum Zitat Jellinger K (1988) The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:540–543PubMedPubMedCentralCrossRef Jellinger K (1988) The pedunculopontine nucleus in Parkinson’s disease, progressive supranuclear palsy and Alzheimer’s disease. J Neurol Neurosurg Psychiatry 51:540–543PubMedPubMedCentralCrossRef
Zurück zum Zitat Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, Barre L, Constans JM, Viader F, Eustache F, Desgranges B (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30(1):112–124PubMedCrossRef Kalpouzos G, Chetelat G, Baron JC, Landeau B, Mevel K, Godeau C, Barre L, Constans JM, Viader F, Eustache F, Desgranges B (2009) Voxel-based mapping of brain gray matter volume and glucose metabolism profiles in normal aging. Neurobiol Aging 30(1):112–124PubMedCrossRef
Zurück zum Zitat Karbe H, Holthoff V, Huber M, Herholz K, Wienhard K, Wagner R, Heiss WD (1992) Positron emission tomography in degenerative disorders of the dopaminergic system. J Neural Transm Park Dis Dement Sect 4:121–130PubMedCrossRef Karbe H, Holthoff V, Huber M, Herholz K, Wienhard K, Wagner R, Heiss WD (1992) Positron emission tomography in degenerative disorders of the dopaminergic system. J Neural Transm Park Dis Dement Sect 4:121–130PubMedCrossRef
Zurück zum Zitat Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, Kinomura S, Fukuda H, Chida K, Okita N, Takase S, Itoyama Y (2001) Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson’s disease. J Neurol Sci 193:29–36PubMedCrossRef Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, Kinomura S, Fukuda H, Chida K, Okita N, Takase S, Itoyama Y (2001) Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson’s disease. J Neurol Sci 193:29–36PubMedCrossRef
Zurück zum Zitat Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM (2002) Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51:237–252PubMedCrossRef Kimbrell TA, Ketter TA, George MS, Little JT, Benson BE, Willis MW, Herscovitch P, Post RM (2002) Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 51:237–252PubMedCrossRef
Zurück zum Zitat Kitamura S, Ujike T, Kuroki S, Sakamoto S, Soeda T, Iio M, Terashi A (1988) Cerebral blood flow and oxygen metabolism in patients with Parkinson’s disease. No To Shinkei 40:979–985PubMed Kitamura S, Ujike T, Kuroki S, Sakamoto S, Soeda T, Iio M, Terashi A (1988) Cerebral blood flow and oxygen metabolism in patients with Parkinson’s disease. No To Shinkei 40:979–985PubMed
Zurück zum Zitat Kondo S, Tanaka M, Sun X, Okamoto K, Hirai S (1994) Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy. Rinsho Shinkeigaku 34:531–537PubMed Kondo S, Tanaka M, Sun X, Okamoto K, Hirai S (1994) Cerebral blood flow and oxygen metabolism in patients with pure akinesia and progressive supranuclear palsy. Rinsho Shinkeigaku 34:531–537PubMed
Zurück zum Zitat Kuhl DE, Metter EJ, Riege WH (1984) Patterns of local cerebral glucose utilization determined in Parkinson’s disease by the [18F]fluorodeoxyglucose method. Ann Neurol 15:419–424PubMedCrossRef Kuhl DE, Metter EJ, Riege WH (1984) Patterns of local cerebral glucose utilization determined in Parkinson’s disease by the [18F]fluorodeoxyglucose method. Ann Neurol 15:419–424PubMedCrossRef
Zurück zum Zitat Lacombe P, Sercombe R, Verrecchia C, Philipson V, MacKenzie ET, Seylaz J (1989) Cortical blood flow increases induced by stimulation of the substantia innominata in the unanesthetized rat. Brain Res 491:1–14PubMedCrossRef Lacombe P, Sercombe R, Verrecchia C, Philipson V, MacKenzie ET, Seylaz J (1989) Cortical blood flow increases induced by stimulation of the substantia innominata in the unanesthetized rat. Brain Res 491:1–14PubMedCrossRef
Zurück zum Zitat Leenders KL, Wolfson L, Gibbs JM, Wise RJ, Causon R, Jones T, Legg NJ (1985) The effects of l-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson’s disease. Brain 108(Pt 1):171–191PubMedCrossRef Leenders KL, Wolfson L, Gibbs JM, Wise RJ, Causon R, Jones T, Legg NJ (1985) The effects of l-DOPA on regional cerebral blood flow and oxygen metabolism in patients with Parkinson’s disease. Brain 108(Pt 1):171–191PubMedCrossRef
Zurück zum Zitat Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson’s disease: test–retest reproducibility. J Cereb Blood Flow Metab 27:597–605PubMedCrossRef Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson’s disease: test–retest reproducibility. J Cereb Blood Flow Metab 27:597–605PubMedCrossRef
Zurück zum Zitat Ma Y, Tang C, Moeller JR, Eidelberg D (2009) Abnormal regional brain function in Parkinson’s disease: truth or fiction? Neuroimage 45:260–266PubMedCrossRef Ma Y, Tang C, Moeller JR, Eidelberg D (2009) Abnormal regional brain function in Parkinson’s disease: truth or fiction? Neuroimage 45:260–266PubMedCrossRef
Zurück zum Zitat Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19:541–547PubMedCrossRef Minoshima S, Frey KA, Foster NL, Kuhl DE (1995) Preserved pontine glucose metabolism in Alzheimer disease: a reference region for functional brain image (PET) analysis. J Comput Assist Tomogr 19:541–547PubMedCrossRef
Zurück zum Zitat Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, Kikuchi S, Sasaki H (2005) Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson’s disease with and without dementia, and Alzheimer’s disease. Clin Neurol Neurosurg 107:396–403PubMedCrossRef Mito Y, Yoshida K, Yabe I, Makino K, Hirotani M, Tashiro K, Kikuchi S, Sasaki H (2005) Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson’s disease with and without dementia, and Alzheimer’s disease. Clin Neurol Neurosurg 107:396–403PubMedCrossRef
Zurück zum Zitat Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA (1987) Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 7:649–658PubMedCrossRef Moeller JR, Strother SC, Sidtis JJ, Rottenberg DA (1987) Scaled subprofile model: a statistical approach to the analysis of functional patterns in positron emission tomographic data. J Cereb Blood Flow Metab 7:649–658PubMedCrossRef
Zurück zum Zitat Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, Missimer J, Leenders KL, Eidelberg D (1999) Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 40:1264–1269PubMed Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, Missimer J, Leenders KL, Eidelberg D (1999) Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 40:1264–1269PubMed
Zurück zum Zitat Montastruc JL, Celsis P, Agniel A, Demonet JF, Doyon B, Puel M, Marc-Vergnes JP, Rascol A (1987) Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson’s disease. Lack of correlation with clinical or neuropsychological improvements. Mov Disord 2:279–289PubMedCrossRef Montastruc JL, Celsis P, Agniel A, Demonet JF, Doyon B, Puel M, Marc-Vergnes JP, Rascol A (1987) Levodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson’s disease. Lack of correlation with clinical or neuropsychological improvements. Mov Disord 2:279–289PubMedCrossRef
Zurück zum Zitat Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224–229PubMedCrossRef Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224–229PubMedCrossRef
Zurück zum Zitat Otsuka M, Ichiya Y, Hosokawa S, Kuwabara Y, Tahara T, Fukumura T, Kato M, Masuda K, Goto I (1991) Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson’s disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 54:898–904PubMedPubMedCentralCrossRef Otsuka M, Ichiya Y, Hosokawa S, Kuwabara Y, Tahara T, Fukumura T, Kato M, Masuda K, Goto I (1991) Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson’s disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 54:898–904PubMedPubMedCentralCrossRef
Zurück zum Zitat Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Yoshida T, Fukumura T, Kato M, Masuda K (1996) Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson’s disease: a positron emission tomographic study. J Neurol Sci 144:77–83PubMedCrossRef Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Yoshida T, Fukumura T, Kato M, Masuda K (1996) Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson’s disease: a positron emission tomographic study. J Neurol Sci 144:77–83PubMedCrossRef
Zurück zum Zitat Peppard RF, Martin WR, Carr GD, Grochowski E, Schulzer M, Guttman M, McGeer PL, Phillips AG, Tsui JK, Calne DB (1992) Cerebral glucose metabolism in Parkinson’s disease with and without dementia. Arch Neurol 49:1262–1268PubMedCrossRef Peppard RF, Martin WR, Carr GD, Grochowski E, Schulzer M, Guttman M, McGeer PL, Phillips AG, Tsui JK, Calne DB (1992) Cerebral glucose metabolism in Parkinson’s disease with and without dementia. Arch Neurol 49:1262–1268PubMedCrossRef
Zurück zum Zitat Perlmutter JS, Raichle ME (1985) Regional blood flow in hemiparkinsonism. Neurology 35:1127–1134PubMedCrossRef Perlmutter JS, Raichle ME (1985) Regional blood flow in hemiparkinsonism. Neurology 35:1127–1134PubMedCrossRef
Zurück zum Zitat Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE (1996) Determination of regional rate constants from dynamic FDG-PET studies in Parkinson’s disease. J Nucl Med 37:1115–1122PubMed Piert M, Koeppe RA, Giordani B, Minoshima S, Kuhl DE (1996) Determination of regional rate constants from dynamic FDG-PET studies in Parkinson’s disease. J Nucl Med 37:1115–1122PubMed
Zurück zum Zitat Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ (1992) Impaired mesial frontal and putamen activation in Parkinson’s disease: a positron emission tomography study. Ann Neurol 32:151–161PubMedCrossRef Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ (1992) Impaired mesial frontal and putamen activation in Parkinson’s disease: a positron emission tomography study. Ann Neurol 32:151–161PubMedCrossRef
Zurück zum Zitat Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS (2008) Cerebral mitochondrial metabolism in early Parkinson’s disease. J Cereb Blood Flow Metab 28:1754–1760PubMedCrossRef Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS (2008) Cerebral mitochondrial metabolism in early Parkinson’s disease. J Cereb Blood Flow Metab 28:1754–1760PubMedCrossRef
Zurück zum Zitat Rougemont D, Baron JC, Collard P, Bustany P, Comar D, Agid Y (1984) Local cerebral glucose utilisation in treated and untreated patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 47:824–830PubMedPubMedCentralCrossRef Rougemont D, Baron JC, Collard P, Bustany P, Comar D, Agid Y (1984) Local cerebral glucose utilisation in treated and untreated patients with Parkinson’s disease. J Neurol Neurosurg Psychiatry 47:824–830PubMedPubMedCentralCrossRef
Zurück zum Zitat Sasaki M, Ichiya Y, Hosokawa S, Otsuka M, Kuwabara Y, Fukumura T, Kato M, Goto I, Masuda K (1992) Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia. Ann Nucl Med 6:241–246PubMedCrossRef Sasaki M, Ichiya Y, Hosokawa S, Otsuka M, Kuwabara Y, Fukumura T, Kato M, Goto I, Masuda K (1992) Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia. Ann Nucl Med 6:241–246PubMedCrossRef
Zurück zum Zitat Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, Pelton GH, Tabert MH, Honig LS, Moeller JR, Devanand DP, Stern Y (2004) Covariance PET patterns in early Alzheimer’s disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage 23:35–45PubMedCrossRef Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, Pelton GH, Tabert MH, Honig LS, Moeller JR, Devanand DP, Stern Y (2004) Covariance PET patterns in early Alzheimer’s disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. Neuroimage 23:35–45PubMedCrossRef
Zurück zum Zitat Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73(4):273–278PubMedCrossRef Shimada H, Hirano S, Shinotoh H, Aotsuka A, Sato K, Tanaka N, Ota T, Asahina M, Fukushi K, Kuwabara S, Hattori T, Suhara T, Irie T (2009) Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 73(4):273–278PubMedCrossRef
Zurück zum Zitat Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D (2006) Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE: Med Imag 6144:5M1–5M12 Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D (2006) Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE: Med Imag 6144:5M1–5M12
Zurück zum Zitat Underwood MD, Bakalian MJ, Arango V, Mann JJ (1995) Effect of chemical stimulation of the dorsal raphe nucleus on cerebral blood flow in rat. Neurosci Lett 199:228–230PubMedCrossRef Underwood MD, Bakalian MJ, Arango V, Mann JJ (1995) Effect of chemical stimulation of the dorsal raphe nucleus on cerebral blood flow in rat. Neurosci Lett 199:228–230PubMedCrossRef
Zurück zum Zitat Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R (2004) Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson’s disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 45:933–942PubMed Van Laere K, Santens P, Bosman T, De Reuck J, Mortelmans L, Dierckx R (2004) Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson’s disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters. J Nucl Med 45:933–942PubMed
Zurück zum Zitat Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE (1997) Cerebral metabolic differences in Parkinson’s and Alzheimer’s diseases matched for dementia severity. J Nucl Med 38:797–802PubMed Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE (1997) Cerebral metabolic differences in Parkinson’s and Alzheimer’s diseases matched for dementia severity. J Nucl Med 38:797–802PubMed
Zurück zum Zitat Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, Rasmussen NA, Andersen F, Gjedde A, Rosenberg R (2002) The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 106:35–44PubMedCrossRef Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, Rasmussen NA, Andersen F, Gjedde A, Rosenberg R (2002) The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 106:35–44PubMedCrossRef
Zurück zum Zitat Wolfson LI, Leenders KL, Brown LL, Jones T (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 35:1399–1405PubMedCrossRef Wolfson LI, Leenders KL, Brown LL, Jones T (1985) Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson’s disease. Neurology 35:1399–1405PubMedCrossRef
Zurück zum Zitat Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996) A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58–73PubMedCrossRef Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996) A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58–73PubMedCrossRef
Zurück zum Zitat Worsley KJ, Liao CH, Aston J, Petre V, Duncan GH, Morales F, Evans AC (2002) A general statistical analysis for fMRI data. Neuroimage 15:1–15PubMedCrossRef Worsley KJ, Liao CH, Aston J, Petre V, Duncan GH, Morales F, Evans AC (2002) A general statistical analysis for fMRI data. Neuroimage 15:1–15PubMedCrossRef
Zurück zum Zitat Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, Peters J, Bartenstein P, Lieb K, Schreckenberger M (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44:43–50PubMedCrossRef Yakushev I, Hammers A, Fellgiebel A, Schmidtmann I, Scheurich A, Buchholz HG, Peters J, Bartenstein P, Lieb K, Schreckenberger M (2009) SPM-based count normalization provides excellent discrimination of mild Alzheimer’s disease and amnestic mild cognitive impairment from healthy aging. Neuroimage 44:43–50PubMedCrossRef
Zurück zum Zitat Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, Matsuda H, Yamada M (2005) Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging 32:794–805PubMedCrossRef Yanase D, Matsunari I, Yajima K, Chen W, Fujikawa A, Nishimura S, Matsuda H, Yamada M (2005) Brain FDG PET study of normal aging in Japanese: effect of atrophy correction. Eur J Nucl Med Mol Imaging 32:794–805PubMedCrossRef
Zurück zum Zitat Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341PubMedCrossRef Zarow C, Lyness SA, Mortimer JA, Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337–341PubMedCrossRef
Metadaten
Titel
Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages
verfasst von
Per Borghammer
Mallar Chakravarty
Kristjana Yr Jonsdottir
Noriko Sato
Hiroshi Matsuda
Kengo Ito
Yutaka Arahata
Takashi Kato
Albert Gjedde
Publikationsdatum
01.05.2010
Verlag
Springer Berlin Heidelberg
Erschienen in
Brain Structure and Function / Ausgabe 4/2010
Print ISSN: 1863-2653
Elektronische ISSN: 1863-2661
DOI
https://doi.org/10.1007/s00429-010-0246-0

Weitere Artikel der Ausgabe 4/2010

Brain Structure and Function 4/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.